The Timing of Emergency Endoscopy for Esophagogastric Variceal Bleeding in Cirrhosis

NCT04932200 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 608

Last updated 2021-06-21

No results posted yet for this study

Summary

This study is a prospective, multi-center and observational clinical study. Investigators would like to explore the optimal emergency endoscopy timing in cirrhosis patients with esophagogastric variceal bleeding (EGVB) by evaluating and comparing the efficacy and safety of emergency endoscopy performed at different times ( within 6 hours or between 6 and 24 hours after gastroenterologic consultation ) and its impact on the short-term prognosis.

Conditions

Sponsors & Collaborators

  • Beijing Friendship Hospital

    collaborator OTHER
  • The First Affiliated Hospital of Nanchang University

    collaborator OTHER
  • Fudan University

    collaborator OTHER
  • Southwest Hospital, China

    collaborator OTHER
  • Beijing Shijitan Hospital, Capital Medical University

    collaborator OTHER
  • Fuyang NO.2 Renmin Hospital

    collaborator UNKNOWN
  • Hubei Hospital of Traditional Chinese Medicine

    collaborator OTHER
  • Wuhan No.1 Hospital

    collaborator OTHER
  • Wuhan Puren Hospital

    collaborator OTHER
  • Tianyou Hospital Affiliated to Wuhan University of Science and Technology

    collaborator OTHER
  • The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture

    collaborator OTHER
  • Yichang Central People's Hospital

    collaborator OTHER
  • Shiyan Renmin Hospital

    collaborator UNKNOWN
  • Hanyang University

    collaborator OTHER
  • The Third People's Hospital of Hubei Province

    collaborator OTHER
  • Chibi Renmin Hospital

    collaborator UNKNOWN
  • Renmin Hospital of Wuhan University

    lead OTHER

Principal Investigators

  • Mingkai Chen, PHD · Renmin Hospital of Wuhan University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-15
Primary Completion
2022-04-30
Completion
2022-04-30

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04932200 on ClinicalTrials.gov